KMID : 1128320140120020055
|
|
Electrolytes & Blood Pressure 2014 Volume.12 No. 2 p.55 ~ p.65
|
|
Cisplatin-induced Kidney Dysfunction and Perspectives on Improving Treatment Strategies
|
|
Oh Gi-Su
Kim Hyung-Jin Ai Hua Shen Lee Su-Bin Dipendra Khadka Arpana Pandit So Hong-Seob
|
|
Abstract
|
|
|
Cisplatin is one of the most widely used and highly effective drug for the treatment of various solid tumors; however, it has dose-dependent side effects on the kidney, cochlear, and nerves. Nephrotoxicity is the most well-known and clinically important toxicity. Numerous studies have demonstrated that several mechanisms, including oxidative stress, DNA damage, and inflammatory res-ponses, are closely associated with cisplatin-induced nephrotoxicity. Even though the establishment of cisplatin-induced nephrotoxicity can be alleviated by diuretics and pre-hydration of patients, the prevalence of cisplatin nephrotoxi- city is still high, occurring in approximately one-third of patients who have under- gone cisplatin therapy. Therefore it is imperative to develop treatments that will ameliorate cisplatin-nephrotoxicity. In this review, we discuss the mechanisms of cisplatin-induced renal toxicity and the new strategies for protecting the kidneys from the toxic effects without lowering the tumoricidal activity.
|
|
KEYWORD
|
|
Cisplatin, Chemotherapy, Nephrotoxicity, NAD
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|
|